Sunday, December 5, 2021

Covid pill

Merck’s Covid-19 pill shows lower efficacy in updated data

The pill shows a 30% reduction in hospitalisations and deaths based on data from over 1,400 patients, compared to about 50% in October based on data from 775 patients.

Pfizer strikes global licensing deal for Covid pill

Pfizer will sub-licence production of its Paxlovid pill to generic drug manufacturers for supply in 95 low- and middle-income nations covering around 53% of the world's population.

Pfizer to conduct trials of antiviral Covid pill in Russia

The trials conducted on 90 people located in home-like conditions with someone who has symptomatic Covid-19 began on Nov 12 and will continue until March 2023.

Covid-19 pills are coming but no substitute for vaccines, disease experts say

Doctors warn vaccine hesitant people not to confuse the benefit of the treatments with prevention afforded by vaccines.

How does Merck’s Covid-19 pill compare to Pfizer’s?

Both drugs are being studied to see if they can prevent infection in people exposed to the virus.

Covid-19 pill to be given for free to symptomatic or late-stage patients

Health Minister Khairy Jamaluddin says the treatment pills are necessary in addition to the vaccination programme.

Govt signs agreement for Merck Covid-19 pill

Health Minister Khairy Jamaluddin says this is part of preparations to transition to the endemic phase of Covid-19.

Merck says research shows its Covid-19 pill works against variants

Data shows that the drug is most effective when given early in the course of infection.

Other News